{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_11896", "batch_size": 200, "batch_pos": 85, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "uncertain", "rationale": "LLM call failed.", "method": "llm_batch", "batch_id": "batch_2_20228", "batch_size": 200, "batch_pos": 35, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "Uses plain verbs ('is too early to tell', 'will be able to manufacture', 'said') not moderate verbs.", "method": "llm_batch", "batch_id": "batch_3_21444", "batch_size": 200, "batch_pos": 182, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_17336", "batch_size": 200, "batch_pos": 179, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports uncertainty but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17156", "batch_size": 200, "batch_pos": 176, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_18488", "batch_size": 200, "batch_pos": 128, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment contains a negation ('too early to tell') but it is about knowledge/certainty, not a bare negation about the virus's properties or impact.", "method": "llm_batch", "batch_id": "batch_7_13612", "batch_size": 200, "batch_pos": 99, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "no", "rationale": "The segment states uncertainty about future manufacturing quantity, not a capability, preparedness measure, or safeguard being implemented.", "method": "llm_batch", "batch_id": "batch_8_15140", "batch_size": 200, "batch_pos": 149, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "The segment discusses difficulty telling how many doses can be manufactured, not reporting prices or metrics.", "method": "llm_batch", "batch_id": "batch_9_16972", "batch_size": 200, "batch_pos": 180, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment states uncertainty about future manufacturing, not relief from the threat.", "method": "llm_batch", "batch_id": "batch_10_20352", "batch_size": 200, "batch_pos": 9, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Quote is a factual statement about manufacturing uncertainty, not dominant framing per Q11.", "method": "llm_batch", "batch_id": "batch_11_18128", "batch_size": 200, "batch_pos": 6, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 12, "answer": "yes", "rationale": "Factual statement about uncertainty with no explicit framing cues.", "method": "llm_batch", "batch_id": "batch_12_20236", "batch_size": 200, "batch_pos": 6, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
